MENU
OKUR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
OnKure Therapeutics (OKUR) Ownership - Who owns OnKure Therapeutics?
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
35.8M
P/E Ratio
62.48
Total Cash
96.66M
Projected Growth
N/A
Total Debt
955K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.15
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
OKUR
Capitalization
35.8M
P/E Ratio
62.48
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
96.7M
Total Cash/Share
7.15
Total Debt
955K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
90.6M
P/B Ratio
0.39
Cash Flow
N/A
Earnings
-4.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
11.17
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-58.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-94.95
Shares Held By Institutions
46.9M
Shares Outstanding - Current
13.5M
Total Liabilities
9.23M
Total Volume MTD
N/A
Value
-1
Gain YTD
-69.186
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information